IMO comments made by Marlin1 in this thread are BS, however, BNB has been strongly hammered in the last few days irrespectively of the “good news” out of the syndicate agreement and without specific knowledge on how the debt to equity is going to be articulated. From the technical analysis, it seems to me like BNB has bottomed and there should be space for a small rally. Reading some of the fundamentals in depth, the NTA reported by BNB 6 months ago indicates the company is worth around $6.5 per share. Now, if I include impairments of up to $1b, the NTA goes down to $3 per share (20 times the actual sp)…We can argue whether that analysis is correct or not, and there will be people saying the sp is given by the market and some other believing BNB is not surviving. IMO BNB will survive and probably the sp will be considerably higher than what it is now, I’m following BNB most specifically because my long term plan is linked with BBI/BBP and I believe that the better BNB performs the better that my portfolio will perform, so honestly, I wish this one rallies and give me some breathing space with my real interest…Marlin1 is not going to affect the sp at all, if he’s saying every day that the sp will raise, eventually he will get it right…so if staying tune makes him/her happy…stay tune, I don’t give a s…
Good luck to all
- Forums
- ASX - By Stock
- this is cheap
BNB
babcock & brown limited
IMO comments made by Marlin1 in this thread are BS, however, BNB...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online